tiprankstipranks
Medicinova (JP:4875)
:4875
Japanese Market
4875
Medicinova
RESEARCH TOOLSreports

Medicinova (4875) Ratios

0 Followers

Medicinova Ratios

JP:4875's free cash flow for Q2 2026 was $0.69. For the 2026 fiscal year, JP:4875's free cash flow was decreased by $ and operating cash flow was $-5.53. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 8.75 8.16 13.88 15.61 18.51
Quick Ratio
 8.75 8.16 13.88 15.61 18.51
Cash Ratio
 8.58 8.11 13.64 15.55 5.81
Solvency Ratio
 -3.40 -2.98 -3.27 -2.20 -3.59
Operating Cash Flow Ratio
 -650.86 -2.58 -3.60 -2.27 -4.05
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 22.76M$ 26.97M$ 37.70M$ 47.28M$ 55.07M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.08 1.10 1.06 1.06 1.06
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 0.01
Net Debt to EBITDA
 2.30 2.56 3.64 5.14 1.22
Profitability Margins
Gross Profit Margin
42.39%7.58%0.00%100.00%0.00%
EBIT Margin
-1191.68%-2927.32%0.00%-990.03%0.00%
EBITDA Margin
-1192.46%-2922.41%0.00%-988.00%0.00%
Operating Profit Margin
-1287.41%-3242.47%0.00%-990.03%0.00%
Pretax Profit Margin
-1167.55%-2927.32%0.00%-856.85%0.00%
Net Profit Margin
-1168.20%-2928.78%0.00%-857.15%0.00%
Continuous Operations Profit Margin
-1168.20%-2928.78%0.00%-857.15%0.00%
Net Income Per EBT
100.06%100.05%100.05%100.04%100.02%
EBT Per EBIT
90.69%90.28%87.13%86.55%96.16%
Return on Assets (ROA)
-26.59%-26.31%-19.78%-12.93%-18.97%
Return on Equity (ROE)
-26.51%-28.85%-21.05%-13.74%-20.03%
Return on Capital Employed (ROCE)
-31.62%-31.77%-23.95%-15.72%-20.61%
Return on Invested Capital (ROIC)
-31.53%-31.63%-23.87%-15.66%-20.57%
Return on Tangible Assets
-41.31%-38.45%-26.64%-16.53%-23.54%
Earnings Yield
-13.40%-18.67%-10.73%-11.65%-13.99%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.56 0.61 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 8.23 2.13 0.00 1.61 0.00
Asset Turnover
 0.02 <0.01 0.00 0.02 0.00
Working Capital Turnover Ratio
 0.04 0.01 0.00 0.02 0.00
Cash Conversion Cycle
 -654.23 -602.53 0.00 0.00 0.00
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 654.23 602.53 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -39.15 -0.20 -0.22 -0.15 -0.26
Free Cash Flow Per Share
 -39.15 -0.20 -0.22 -0.15 -0.26
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -178.00K -3.38K -11.89K -348.89 -2.58K
Capital Expenditure Coverage Ratio
 -178.00K -3.38K -11.89K -348.89 -2.58K
Operating Cash Flow Coverage Ratio
 -16.47K -50.48 -54.93 -34.41 -18.96
Operating Cash Flow to Sales Ratio
 -2.09K -23.95 0.00 -7.43 0.00
Free Cash Flow Yield
-2402.14%-15.27%-10.33%-10.13%-12.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -7.50 -5.46 -9.13 -8.58 -7.15
Price-to-Sales (P/S) Ratio
 87.16 156.89 0.00 73.57 0.00
Price-to-Book (P/B) Ratio
 2.15 1.55 1.96 1.18 1.43
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.04 -6.55 -9.68 -9.87 -7.78
Price-to-Operating Cash Flow Ratio
 -0.04 -6.55 -9.68 -9.90 -7.79
Price-to-Earnings Growth (PEG) Ratio
 -0.86 -1.26 -0.26 0.21 -0.19
Price-to-Fair Value
 2.15 1.55 1.96 1.18 1.43
Enterprise Value Multiple
 -5.00 -2.81 -5.70 -2.31 -5.66
Enterprise Value
 54.93M 33.66M 62.83M 22.79M 82.72M
EV to EBITDA
 -5.00 -2.81 -5.70 -2.31 -5.66
EV to Sales
 59.68 82.17 0.00 22.79 0.00
EV to Free Cash Flow
 -0.03 -3.43 -5.90 -3.06 -6.40
EV to Operating Cash Flow
 -0.03 -3.43 -5.90 -3.07 -6.41
Tangible Book Value Per Share
 0.46 0.55 0.78 0.98 1.14
Shareholders’ Equity Per Share
 0.76 0.85 1.07 1.27 1.43
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 0.02 <0.01 0.00 0.02 0.00
Net Income Per Share
 -0.22 -0.24 -0.23 -0.17 -0.29
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.98 1.00 1.00 0.87 0.96
Research & Development to Revenue
 1.38K 17.47 0.00 5.66 0.00
SG&A to Revenue
 1.73K 15.04 0.00 4.98 0.00
Stock-Based Compensation to Revenue
 192.85 2.02 0.00 0.71 0.00
Income Quality
 0.83 0.82 0.96 0.87 0.92
Currency in USD